Imagen de Portada

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.

Fuente: Zenodo

Guardado en:

Detalles Bibliográficos
Autor principal:	Mamoor, Shahan
Formato:	Recurso digital
Publicado:	Zenodo 2025
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
por: Mamoor, Shahan
Publicado: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
por: Mamoor, Shahan
Publicado: (2025)

ATM defects result in Xist modulation.
por: Mamoor, Shahan
Publicado: (2025)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
por: Mamoor, Shahan
Publicado: (2025)

Telomerase control of Xist through Trf2.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
por: Mamoor, Shahan
Publicado: (2025)

The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
por: Mamoor, Shahan
Publicado: (2025)

Deletion of repeat B and C of Xist results in induction of SATB1.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: ENOPH1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: MTFP1.
por: Mamoor, Shahan
Publicado: (2025)

BAALC: Therapeutic targeting in lung cancer for the treatment of lymph node metastasis.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: WNK3.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PANK1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: FJX1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: RPL19.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PFKFB4.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: SHMT2.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in lung cancer for the treatment of lymph node metastasis: CAMTA1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in lung cancer for the treatment of lymph node metastasis: GRIK3.
por: Mamoor, Shahan
Publicado: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of lung metastasis: EREG.
por: Mamoor, Shahan
Publicado: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of lung metastasis: CTNNBL1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP6R1.
por: Mamoor, Shahan
Publicado: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of lung metastasis: GRIK4.
por: Mamoor, Shahan
Publicado: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of lung metastasis: ATAD1.
por: Mamoor, Shahan
Publicado: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of lung metastasis: GPR158.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP1R9A.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP1R9A.
por: Mamoor, Shahan
Publicado: (2025)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: HOXB7.
por: Mamoor, Shahan
Publicado: (2025)

Phosphatase targeting in Luminal B breast cancer: PGP.
por: Mamoor, Shahan
Publicado: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
por: Mamoor, Shahan
Publicado: (2025)

Kinase targeting in Luminal B breast cancer: DTYMK.
por: Mamoor, Shahan
Publicado: (2025)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
por: Mamoor, Shahan
Publicado: (2025)

Genes that function in axon guidance are associated with disease progression in breast and lung cancer.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in colorectal cancer for the treatment of liver metastasis: MAF.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: HHEX.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: BAAT.
por: Mamoor, Shahan
Publicado: (2025)

Kinase targeting in Luminal B breast cancer: CDK5.
por: Mamoor, Shahan
Publicado: (2025)